CAXTON CORP Diversified Active

Location: Princeton, NJ

CIK: 0001388551 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 14, 2019

Total Value: $108M (100.0% shares, 0.0% debt)

Holdings (26)

— STRONGBRIDGE BIOPHARMA PLC 30.6%
Value $32.93M Shares 6,612,065 Share Price $4.98 Est. Cost/Share $2.92 Unrealized @ Report Date —
— KALA PHARMACEUTICALS INC 11.5%
Value $12.42M Shares 1,501,272 Share Price $8.27 Est. Cost/Share $5.38 Unrealized @ Report Date —
— MEI PHARMA INC 9.9%
Value $10.62M Shares 3,459,124 Share Price $3.07 Est. Cost/Share $3.94 Unrealized @ Report Date —
— MOLECULAR TEMPLATES INC 8.8%
Value $9.437M Shares 1,624,241 Share Price $5.81 Est. Cost/Share $6.39 Unrealized @ Report Date —
— GARRISON CAP INC 8.2%
Value $8.796M Shares 1,225,096 Share Price $7.18 Est. Cost/Share $8.25 Unrealized @ Report Date —
— SCYNEXIS INC 6.1%
Value $6.531M Shares 4,325,000 Share Price $1.51 Est. Cost/Share $1.30 Unrealized @ Report Date —
— CM FIN INC 5.9%
Value $6.322M Shares 856,673 Share Price $7.38 Est. Cost/Share $8.08 Unrealized @ Report Date —
— ALCENTRA CAP CORP 5.6%
Value $6M Shares 800,000 Share Price $7.50 Est. Cost/Share $7.53 Unrealized @ Report Date —
— ALPS ETF TR 3.8%
Value $4.131M Shares 411,892 Share Price $10.03 Est. Cost/Share $10.10 Unrealized @ Report Date —
SPY SPDR S&P 500 ETF TR 3.7%
Value $3.958M Shares 14,010 Share Price $282.51 Est. Cost/Share $249.89 Unrealized @ Report Date —
BRK/B BERKSHIRE HATHAWAY INC DEL 1.7%
Value $1.871M Shares 9,312 Share Price $200.92 Est. Cost/Share $135.71 Unrealized @ Report Date +48.7%
— ARQULE INC 0.6%
Value $700K Shares 146,066 Share Price $4.79 Est. Cost/Share $4.85 Unrealized @ Report Date —
— EIGER BIOPHARMACEUTICALS INC 0.6%
Value $689K Shares 49,285 Share Price $13.98 Est. Cost/Share $11.54 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 0.3%
Value $337K Shares 277,245 Share Price $1.22 Est. Cost/Share $1.22 Unrealized @ Report Date —
KURA KURA ONCOLOGY INC 0.3%
Value $320K Shares 19,274 Share Price $16.60 * Est. Cost/Share $18.11 Unrealized @ Report Date -14.9%
— CTI BIOPHARMA CORP 0.3%
Value $313K Shares 323,026 Share Price $0.97 Est. Cost/Share $1.43 Unrealized @ Report Date —
GSM FERROGLOBE PLC 0.3%
Value $285K Shares 139,226 Share Price $2.05 * Est. Cost/Share $2.22 Unrealized @ Report Date 0.0%
— MARKER THERAPEUTICS INC 0.3%
Value $280K Shares 42,374 Share Price $6.61 Est. Cost/Share $5.55 Unrealized @ Report Date —
— FAR PT ACQUISITION CORP 0.2%
Value $253K Shares 25,453 Share Price $9.94 Est. Cost/Share $9.66 Unrealized @ Report Date —
— SPRING BK PHARMACEUTICALS IN 0.2%
Value $249K Shares 23,717 Share Price $10.50 Est. Cost/Share $11.88 Unrealized @ Report Date —
— FS KKR CAPITAL CORP 0.2%
Value $245K Shares 40,458 Share Price $6.06 Est. Cost/Share $5.18 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 0.2%
Value $230K Shares 15,727 Share Price $14.62 Est. Cost/Share $15.21 Unrealized @ Report Date —
MELI MERCADOLIBRE INC 0.2%
Value $221K Shares 435 Share Price $508.05 * Est. Cost/Share $398.69 Unrealized @ Report Date 0.0%
AMT AMERICAN TOWER CORP NEW 0.2%
Value $216K Shares 1,097 Share Price $196.90 * Est. Cost/Share $146.03 Unrealized @ Report Date 0.0%
CACC CREDIT ACCEP CORP MICH 0.2%
Value $208K Shares 460 Share Price $452.17 * Est. Cost/Share $430.38 Unrealized @ Report Date 0.0%
TDG TRANSDIGM GROUP INC 0.2%
Value $208K Shares 458 Share Price $454.15 * Est. Cost/Share $301.26 Unrealized @ Report Date 0.0%